Schroder Income Growth Fund plc (SCF) Ordinary 10p
Sell:274.00p
Buy:275.00p
0
Change:
4.00p
(1.46%)
4.00p
(1.46%)
FTSE All Share:0.18%
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:274.00p
Buy:275.00p
Change:
4.00p
(1.46%)
4.00p
(1.46%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:274.00p
Buy:275.00p
Change:
4.00p
(1.46%)
4.00p
(1.46%)
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
To provide real growth of income, being growth of income in excess of the rate of inflation, and capital growth as a consequence of the rising income. The investment policy of the Company is to invest primarily in UK equities but up to 20% of the portfolio may be invested in equities listed on recognised stock exchanges outside the UK and up to 10% of the portfolio may be invested in bonds. In addition, up to 20% of total income may be generated by short-dated call options written on holdings in the portfolio.
| Security | Weight |
|---|---|
| Shell plc Ordinary EUR0.07 | 7.00% |
| AstraZeneca plc Ordinary US$0.25 | 6.69% |
| HSBC Holdings plc Ordinary USD0.50 | 5.00% |
| GSK plc ORD GBP0.3125 | 4.44% |
| 3i Group Ordinary 73 19/22p | 4.27% |
| Unilever plc Ordinary 3.11p | 4.24% |
| Standard Chartered plc Ordinary US$0.50 | 4.23% |
| National Grid Ord 12, 204/473p | 4.01% |
| Intermediate Capital Group Ord GBP0.2625 | 3.51% |
| Glencore plc Ord USD0.01 | 3.50% |
| Sector | Weight |
|---|---|
| Financial Services | 26.65% |
| Healthcare | 15.95% |
| Consumer Cyclical | 13.24% |
| Consumer Defensive | 9.69% |
| Utilities | 9.09% |
| Industrials | 8.75% |
| Basic Materials | 7.36% |
| Communication Services | 7.12% |
| Energy | 7.00% |
| Real Estate | 3.49% |
| Country | Weight |
|---|---|
| United Kingdom | 105.77% |
| Switzerland | 3.50% |
| China | 0.00% |
| Canada | 0.00% |
| Australia | 0.00% |
Fee Structure
The management fee is a flat 0.45% of the value of the Companys assets.
Dividend Policy
The Directors of the Company intend to continue to pay four interim dividends at the end of January, April, July and October in each year. Although it is intended to distribute substantially all of the net income of Company after expenses and taxation, the Company may retain up to a maximum of 15% of the gross income of the Company in each year as a revenue reserve to provide consistency in dividend policy.
ASSET SPLIT
Trust Manager
Sue Noffke
Manager Bio
Sue Noffke is Head of UK Equities and a UK Equity Fund Manager at Schroders. She is a founding member of the Prime UK Equity team established in 2006. She is fund manager of the Schroder Income Growth Fund plc co-manager of the Schroder Prime UK Equity Fund, the Schroder UK Alpha Income Fund and Cazenove Charity Equity Income Fund. Sue has managed UK equity portfolios for institutional clients since 1993. She joined Schroders in 1989 and was initially an analyst at Schroders responsible for insurance, tobacco and retail sectors in the UK market. Qualifications: Honorary Doctorate Degree from Aston University; BSc in Business Administration and Biochemistry from Aston University.
Board Of Directors
Ewen Cameron-WattChairman, Victoria Muir, June Aitken, Fraser McIntyre
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.